Bupivacaine Hydrochloride in Dextrose Injection
»Bupivacaine Hydrochloride in Dextrose Injection is a sterile solution of Bupivacaine Hydrochloride and Dextrose in Water for Injection.It contains not less than 93.0percent and not more than 107.0percent of the labeled amounts of bupivacaine hydrochloride (C18H28N2O·HCl)and dextrose (C6H12O6).It contains no preservative.
Packaging and storage— Preserve in single-dose containers,preferably of Type Iglass.
Identification—
Adsorbent: chromatographic silica gel mixture;0.25mm.
Developing solvent: mixture of butyl alcohol,water,dehydrated alcohol,and glacial acetic acid (6:2:1:1).
Test preparation: Bupivacaine Hydrochloride in Dextrose Injection.
Standard preparations A ,B,and C—Separately prepare (A)a solution of USP Bupivacaine Hydrochloride RSin water,(B)a solution of USP Dextrose RSin water,and (C)a solution of USP Bupivacaine Hydrochloride RSin (B)to obtain solutions having concentrations corresponding to the labeled concentrations of bupivacaine hydrochloride and dextrose in the Injection.
Naphthalenediol reagent— Dissolve 20mg of 1,3-naphthalenediol in 10mLof dehydrated alcohol containing 0.2mLof sulfuric acid.
Iodoplatinate reagent— Mix equal volumes of platinic chloride solution (3in 1000)and potassium iodide solution (6in 100).
Procedure— Separately apply 10µLeach of the Test preparationand Standard preparations Aand Cto a portion of the chromatographic plate,and separately apply 1µLeach of the Test preparationand Standard preparation Bto the remaining portion of the plate.Dry the applications in a current of warm air,develop the chromatograms,remove the plate from the developing chamber,and mark the solvent front.Dry the plate in warm circulating air,and examine the plate under short-wavelength UVlight:the RFvalue of the principal spot obtained from the Test preparationcorresponds to the spots obtained from the adjacent chromatograms of Standard preparations Aand C.Spray the plate with Naphthalenediol reagent,heat at 90for 5minutes,and examine the plate:the RFvalue of the principal blue-purple spot obtained from the Test preparationcorresponds to that obtained in the adjacent chromatogram of Standard preparation B.Cool the plate,spray it with Iodoplatinate reagent,and examine the plate:bupivacaine appears as a blue-purple spot on a salmon-colored background,and the dextrose spots fade slightly:the RFvalue of the bupivacaine spot obtained from the Test preparationcorresponds to those obtained from the adjacent chromatograms of Standard preparations Aand C.
B: It responds to Identificationtest Bunder Bupivacaine Hydrochloride Injection.
Bacterial endotoxins á85ñ It contains not more than 1.8USP Endotoxin Units per mg of bupivacaine hydrochloride.
pHá791ñ: between 4.0and 6.5.
Other requirements— It meets the requirements under Injections á1ñ.
Assay for bupivacaine hydrochloride—
pH6.8phosphate buffer ,Mobile phase,Internal standard solution,Standard preparation,Chromatographic system,and Procedure—Proceed as directed in the Assayunder Bupivacaine Hydrochloride Injection.
Assay preparation— Transfer an accurately measured volume of Injection,equivalent to about 50mg of bupivacaine hydrochloride,to a 100-mLvolumetric flask,add 10.0mLof Internal standard solution,dilute with methanol to volume,and mix.
Assay for dextrose— Determine the angular rotation of Injection in a suitable polarimeter tube (see Optical Rotation á781ñ).The observed rotation,in degrees,multiplied by 9.452A,in which Ais the ratio of 200divided by the length,in mm,of the polarimeter tube employed,represents the weight,in mg,of dextrose (C6H12O6)in each mLof the Injection.
Auxiliary Information— Staff Liaison:Karen A Russo,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28–NF23Page 294
Pharmacopeial Forum:Volume No.30(5)Page 1590
Phone Number:1-301-816-8379